HB Wealth Management’s Organon & Co OGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$163K Sell
12,062
-3,671
-23% -$43.9K ﹤0.01% 1618
2026
Q1
$94.2K Buy
15,733
+4,423
+39% +$33.3K ﹤0.01% 1506
2025
Q4
$81.1K Sell
11,310
-2,372
-17% -$18.7K ﹤0.01% 1371
2025
Q3
$146K Buy
13,682
+2,743
+25% +$26.9K ﹤0.01% 1295
2025
Q2
$106K Sell
10,939
-10,750
-50% -$111K ﹤0.01% 1133
2025
Q1
$323K Buy
21,689
+3,575
+20% +$55K ﹤0.01% 932
2024
Q4
$270K Buy
18,114
+7,081
+64% +$115K ﹤0.01% 850
2024
Q3
$211K Sell
11,033
-1,792
-14% -$37.1K ﹤0.01% 872
2024
Q2
$265K Buy
12,825
+1,246
+11% +$24.8K ﹤0.01% 755
2024
Q1
$218K Buy
+11,579
New +$199K ﹤0.01% 772
2022
Q3
Sell
-7,980
Closed -$269K 607
2022
Q2
$269K Buy
7,980
+2,042
+34% +$71.5K 0.01% 465
2022
Q1
$207K Buy
+5,938
New +$203K ﹤0.01% 560

Other funds holding OGN

HB Wealth Management's OGN Position: Q2 2026 in Review

HB Wealth Management reduced its Organon & Co (OGN) stake by 23% in Q2 2026, selling an estimated $43.9K and leaving 12,062 shares worth $163K. The position accounts for ﹤0.01% of the portfolio, ranked #1618.

HB Wealth Management first reported a position in OGN in Q1 2022 and has held it in 12 quarters since. The position peaked at $323K in Q1 2025. 631 funds tracked by Wall St. Rank hold OGN as of Q2 2026.

  • HB Wealth Management held 12,062 shares of Organon & Co worth $163K as of Q2 2026.
  • HB Wealth Management sold 3,671 Organon & Co shares in Q2 2026, an estimated $43.9K.
  • Organon & Co made up ﹤0.01% of HB Wealth Management's portfolio in Q2 2026, its #1618 holding.
  • HB Wealth Management first reported a position in Organon & Co in Q1 2022 and has held it in 12 quarters since.
  • HB Wealth Management's Organon & Co position peaked at $323K in Q1 2025.
  • 631 funds tracked by Wall St. Rank held Organon & Co as of Q2 2026.

Based on HB Wealth Management's 13F filing for Q2 2026, filed 29 Jul 2026.